Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection

[21] Bosch FX(2017)The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis Sex Transm Infect 93 56-106

[22] Kummer JA(2007)Process of care failures in invasive cervical cancer: systematic review and meta-analysis Prev Med 45 93-155

[23] Shah KV(2018)Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador Prev Med 114 149-290

[24] Arbyn M(2016)Home-based HPV self-sampling improves participation by never-screened and under-screened women: results from a large randomized trial (iPap) in Australia Int J Cancer 139 281-920

[25] Snijders PJ(2011)HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial Br J Cancer 104 915-245

[26] Meijer CJ(2007)High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening Acta Derm Venereol 87 243-2687

[27] Berkhof J(2013)HPV self-sampling or the pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France Int J Cancer 133 2681-386

[28] Cuschieri K(2019)Detection of HPV mRNA in Self-collected Vaginal Samples Among Women at 69–70 Years of Age Anticancer Res 39 381-171

[29] Kocjan BJ(2013)Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial Int J Cancer 133 164-undefined

[30] Reid JL(undefined)undefined undefined undefined undefined-undefined

[21] Bosch FX(2017)The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis Sex Transm Infect 93 56-106

[22] Kummer JA(2007)Process of care failures in invasive cervical cancer: systematic review and meta-analysis Prev Med 45 93-155

[23] Shah KV(2018)Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador Prev Med 114 149-290

[24] Arbyn M(2016)Home-based HPV self-sampling improves participation by never-screened and under-screened women: results from a large randomized trial (iPap) in Australia Int J Cancer 139 281-920

[25] Snijders PJ(2011)HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial Br J Cancer 104 915-245

[26] Meijer CJ(2007)High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening Acta Derm Venereol 87 243-2687

[27] Berkhof J(2013)HPV self-sampling or the pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France Int J Cancer 133 2681-386

[28] Cuschieri K(2019)Detection of HPV mRNA in Self-collected Vaginal Samples Among Women at 69–70 Years of Age Anticancer Res 39 381-171

[29] Kocjan BJ(2013)Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial Int J Cancer 133 164-undefined

[30] Reid JL(undefined)undefined undefined undefined undefined-undefined